January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...

HexemBio has launched with a seed round led by Draper Associates to advance a blood stem cell rejuvenation therapy backed by Robert Langer.

Treatment represents a new approach that could potentially restore brain cells lost due to Parkinson’s disease ...

A feat once deemed impossible has been accomplished --- the deprogramming of a fully differentiated human cell into an embryonic stem cell. Two laboratories report a breakthrough that may one day ...

A study published in Cell Research advances a central idea in stem cell biology by identifying a checkpoint that controls the ...

Over the last two and a half decades, advancements in stem cell biology and immunology have improved the potential for cell therapy as a treatment for diabetes. Stem cells from different sources can ...

Geron Corp., the company that started the first U.S.-approved trial of human embryonic stem cells, fell the most in more than 11 years after research costs and regulatory complexities caused it to end ...

A new stem cell treatment may offer hope for Parkinson's disease. Keck Medicine of USC is investigating a unique therapy that aims to repair damaged brain cells.

Researchers at Umeå University have contributed new insights into how cancer cells protect themselves from cell death. The ...